The company priced 3.7 million units of securities at $1.35 per share, according to an Oct. 7 news release.
Bone Biologics also granted underwriters the option to purchase up to 566,666 additional shares of common stock.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
